Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 12/20 | 0.55 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.43 |
| ▸ | HTR2B | P41595 | 2/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | MMP12 | P39900 | 4/20 | 0.41 |
| ▸ | MLYCD | O95822 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4267018 | 1.00 | MCHR1 (0.55) | MCHR1CXCR3ADRA2AADRA1AHTR2B | |
| SCHEMBL4262300 | 0.97 | MCHR1 (0.58) | MCHR1CXCR3ADRA2AADRA1AHTR2B | |
| SCHEMBL4262303 | 0.97 | MCHR1 (0.58) | MCHR1CXCR3ADRA2AADRA1AHTR2B | |
| SCHEMBL4255508 | 0.88 | MCHR1 (0.51) | MCHR1CXCR3ADRA2AADRA1AHTR2B | |
| SCHEMBL4255504 | 0.88 | MCHR1 (0.51) | MCHR1CXCR3ADRA2AADRA1AHTR2B | |
| SCHEMBL4266256 | 0.86 | MCHR1 (0.56) | MCHR1ADRA2AADRA1AHTR2BHRH1 | |
| SCHEMBL4266250 | 0.86 | MCHR1 (0.56) | MCHR1ADRA2AADRA1AHTR2BHRH1 | |
| SCHEMBL4259739 | 0.85 | MCHR1 (0.73) | MCHR1ADRA2AADRA1AHTR2BHRH1 | |
| SCHEMBL4259743 | 0.85 | MCHR1 (0.73) | MCHR1ADRA2AADRA1AHTR2BHRH1 | |
| Trifluoroacetic Acid SCHEMBL4255596 | 0.85 | MCHR1 (0.60) | MCHR1ADRA2AADRA1AHTR2BHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036448-A1 | PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMECUTICAL CO., LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036448-A1 | PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | GPR119, HCRTR2, MCHR1 | MCHR1 3/4885CXCR3 1312/4885ADRA2A 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.